tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine has been researched along with morphine in 3 studies
| Studies (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Trials (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Recent Studies (post-2010) (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickenson, AH; Stanfa, LC; Sullivan, AF | 1 |
| Dickenson, AH; Kalso, EA; McQuay, HJ; Sullivan, AF | 1 |
| Dickenson, AH; Kalso, EA; McQuay, HJ; Roques, BP; Sullivan, AF | 1 |
3 other study(ies) available for tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine and morphine
| Article | Year |
|---|---|
Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation.
Topics: Animals; Benzeneacetamides; Carrageenan; Dose-Response Relationship, Drug; Injections, Spinal; Male; Morphine; Myelitis; Naloxone; Neurons; Oligopeptides; Palliative Care; Pyrrolidines; Rats; Rats, Sprague-Dawley | 1992 |
Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
Topics: Amino Acid Sequence; Analgesics; Animals; Dose-Response Relationship, Drug; Indoles; Injections, Spinal; Male; Molecular Sequence Data; Morphinans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta | 1992 |
Cross-tolerance between mu opioid and alpha-2 adrenergic receptors, but not between mu and delta opioid receptors in the spinal cord of the rat.
Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Behavior, Animal; Drug Tolerance; Evoked Potentials; Imidazoles; Male; Medetomidine; Molecular Sequence Data; Morphine; Neurons; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Opioid, delta; Receptors, Opioid, mu; Spinal Cord | 1993 |